▼ -3.05% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for The Joint in the last 3 months. The average price target is $51.20, with a high forecast of $60.00 and a low forecast of $38.00. The average price target represents a -3.05% upside from the last price of $52.81.
The current consensus among 5 contributing investment analysts is to buy stock in The Joint. This Buy consensus rating has held steady for over two years.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of December 31, 2020, the company operated approximately 515 clinics operated or managed by franchisees and 64 company-owned or managed clinics in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.